Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
Appropriate use criteria for imaging in nonvalvular heart disease released
- Author:
- Christopher Palmer
Publish date: January 7, 2019
News

Pembrolizumab approved for Merkel cell carcinoma
- Author:
- Christopher Palmer
Publish date: December 20, 2018
News

A case of cold burn reported with whole-body cryotherapy
- Author:
- Christopher Palmer
Publish date: December 13, 2018
News

Self-report of prenatal marijuana use not very reliable
- Author:
- Christopher Palmer
Publish date: December 10, 2018
News
Phase 3 study of novel pemphigus treatment is initiated
- Author:
- Christopher Palmer
Publish date: December 4, 2018
News

Firdapse approved: First treatment for rare autoimmune disorder
- Author:
- Christopher Palmer
Publish date: November 30, 2018
News

Temixys plus other antiretrovirals approved for HIV-1
- Author:
- Christopher Palmer
Publish date: November 27, 2018
News
Comorbid depression, anxiety linked to doubled risk of diabetes
- Author:
- Christopher Palmer
Publish date: November 26, 2018
News

Some statins worse than others for musculoskeletal adverse event onset time
- Author:
- Christopher Palmer
Publish date: November 8, 2018
News

Physical activity tied to lower depression risk among older adults
- Author:
- Christopher Palmer
Publish date: November 8, 2018
News
ICYMI: Alirocumab improves cardiovascular outcomes
- Author:
- Christopher Palmer
Publish date: November 7, 2018
News

FDA approves Sympazan for Lennox-Gastaut syndrome
- Author:
- Christopher Palmer
Publish date: November 5, 2018
News

Age, insurance type tied to delay in pediatric febrile UTI treatment
- Author:
- Christopher Palmer
Publish date: October 23, 2018
News

FDA approves DNA-based blood type test
- Author:
- Christopher Palmer
Publish date: October 12, 2018
News

FDA approves emicizumab for hemophilia A without inhibitors
- Author:
- Christopher Palmer
Publish date: October 4, 2018
